Overview
Autosomal recessive carpotarsal osteolysis (also known as multicentric carpotarsal osteolysis with or without nephropathy, autosomal recessive type) is an extremely rare inherited skeletal disorder characterized by progressive destruction (osteolysis) of the carpal bones (wrist) and tarsal bones (ankle). The condition typically presents in childhood with pain, swelling, and progressive loss of function in the hands and feet as the small bones gradually dissolve and are resorbed. Affected individuals may develop significant disability due to the progressive nature of the bone destruction, which can also involve other skeletal sites. Some patients may develop additional features including nephropathy (kidney disease), which can progress to renal failure and significantly impact prognosis. The disease follows an autosomal recessive inheritance pattern, meaning that both copies of the responsible gene must carry a pathogenic variant for the condition to manifest. The exact genetic basis of the autosomal recessive form remains incompletely characterized, distinguishing it from the autosomal dominant form of multicentric osteolysis which has been linked to mutations in the MAFB gene. The skeletal and renal systems are the primary organ systems affected. Diagnosis is typically based on clinical findings and radiographic evidence of progressive osteolysis of the carpal and tarsal bones, combined with family history consistent with recessive inheritance. There is currently no curative treatment for autosomal recessive carpotarsal osteolysis. Management is supportive and symptomatic, focusing on pain control, physical and occupational therapy to maintain function, orthopedic interventions as needed, and monitoring of renal function. In cases where nephropathy progresses to end-stage renal disease, dialysis or kidney transplantation may be required. Given the extreme rarity of this condition, management is best coordinated through multidisciplinary teams at centers experienced in rare skeletal disorders.
Also known as:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Autosomal recessive carpotarsal osteolysis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal recessive carpotarsal osteolysis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Autosomal recessive carpotarsal osteolysis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal recessive carpotarsal osteolysis.
Community
No community posts yet. Be the first to share your experience with Autosomal recessive carpotarsal osteolysis.
Start the conversation →Latest news about Autosomal recessive carpotarsal osteolysis
No recent news articles for Autosomal recessive carpotarsal osteolysis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Autosomal recessive carpotarsal osteolysis
What is Autosomal recessive carpotarsal osteolysis?
Autosomal recessive carpotarsal osteolysis (also known as multicentric carpotarsal osteolysis with or without nephropathy, autosomal recessive type) is an extremely rare inherited skeletal disorder characterized by progressive destruction (osteolysis) of the carpal bones (wrist) and tarsal bones (ankle). The condition typically presents in childhood with pain, swelling, and progressive loss of function in the hands and feet as the small bones gradually dissolve and are resorbed. Affected individuals may develop significant disability due to the progressive nature of the bone destruction, which
How is Autosomal recessive carpotarsal osteolysis inherited?
Autosomal recessive carpotarsal osteolysis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Autosomal recessive carpotarsal osteolysis typically begin?
Typical onset of Autosomal recessive carpotarsal osteolysis is childhood. Age of onset can vary across affected individuals.